Who Paid My Doc
Kisria Rechul
Obesity Medicine Albuquerque, NM Medical Doctor
NPI 1265886782 CMS profile 8211846
3500 Comanche Rd Ne Ste C, Albuquerque, NM 87107
General payments
$5,232
Research payments
$3,266
Ownership & investment interest
$0
Research they led as principal investigator
$320,415
Through program year 2025, Kisria Rechul of Albuquerque, NM is reported in the CMS Open Payments database as having received $5,232 across 3 general payments and $3,266 in research payments paid to them. Separately, studies naming them as principal investigator received $320,415 in research payments, paid to institutions rather than to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.
By program year
4 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $5,175 | 2 | |
| 2025 | Research | $1,636 | 1 | |
| 2024 | Research | $1,630 | 1 | |
| 2023 | General | $57 | 1 |
Beside peers
- Kisria Rechul
- Obesity Medicine median
- Middle half of Obesity Medicine
- National median
In program year 2025, general payments to Kisria Rechul were reported at $5,175. Among 30 Obesity Medicine profiles paid that year, the median was $190 and the middle half received between $125 and $2,258.
Show as a table
| Year | Kisria Rechul | Obesity Medicine median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $0 | $128 | $31–$684 | $163 |
| 2020 | $0 | — | — | $114 |
| 2021 | $0 | $140 | $105–$307 | $132 |
| 2022 | $0 | $94 | $36–$376 | $149 |
| 2023 | $57 | $118 | $44–$1,006 | $160 |
| 2024 | $0 | $122 | $75–$730 | $164 |
| 2025 | $5,175 | $190 | $125–$2,258 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Records
5 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Related records
Obesity Medicine in New Mexico
Practitioners in the same specialty and state, ranked by reported value.
All Obesity Medicine
Everyone recorded under this specialty, nationwide.
Doctors in New Mexico
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.